biotech · Colorectal Cancer · Psoriatic Arthritis, Rheumatoid Arthritis · CRDF
Cardiff Oncology
Cardiff Oncology clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 11055 Flintkote Avenue, San Diego, California 92121, US
- Founded
- 1999
- Employees
- 51
- Programs
- 58
- Drugs
- 62
- Patents
- 69
Cardiff Oncology projects
8 ClinicalTrials.gov programs sponsored by Cardiff Oncology.
Cardiff Oncology has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Atenolol
Cardiff Oncology
Marfan Syndrome
1 trial -
Bimatoprost
Cardiff Oncology
Graves' Ophthalmopathy
1 trial -
Carvedilol
Cardiff Oncology
Cirrhoses, Liver
1 trial -
Carvedilol
Cardiff Oncology
Cirrhosis, Liver
1 trial -
Folic Acid
Cardiff Oncology
Depression
1 trial -
Pharmacokinetic based dosage change
Cardiff Oncology
Severe Haemophilia A
1 trial -
Synacthen (Tetracosactrin)
Cardiff Oncology
Healthy
1 trial -
ketamine
Cardiff Oncology
Healthy Volunteers
1 trial
Frequently asked questions
How many clinical projects does Cardiff Oncology have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.